Report
Global Healthcare Industry
This Q1 2022 review examines M&A and capital market activity in the global healthcare industry amid a more challenging economic and geopolitical environment. After strong growth in 2021, the sector faced increased uncertainty due to the ongoing effects of COVID-19, geopolitical tensions, market volatility, inflationary pressures, and supply chain disruptions. While widespread vaccination programs in many advanced economies supported healthcare demand and investor confidence, recurring outbreaks and lockdowns, particularly in China, created new operational and supply chain challenges. Concerns about potential new COVID-19 variants further contributed to market uncertainty. Despite these headwinds, healthcare remained an attractive sector for investors due to its defensive characteristics, i
